Extracellular Matrix Market Key Players and Opportunities by 2028

The extracellular matrix market is projected to reach US$ 52.72 million by 2028 from US$ 31.49 million in 2021. It is estimated to grow at a CAGR of 7.6% from 2021 to 2028.

The extracellular matrix is present in the outer side of the tissues, and it helps tissues bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans, and proteoglycans. Extracellular matrix enables recipient cells to regrow, and thus, it is used in various applications, including cardiac and vascular repair procedures. Several factors, such as the significant rising incidence of cardiovascular diseases and trauma and an increase in vascular reconstruction procedures, are boosting the extracellular matrix market growth. However, the challenges during the usage of decellularized extracellular matrix hamper the market's growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Extracellular Matrix Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Rising Incidences of Cardiovascular Disorders and Trauma Boosts Extracellular Matrix Market Growth

The significant rise in the cases of orthopedic trauma conditions and cardiovascular diseases is the leading factor behind the growth of the global extracellular matrix market. As a part of the treatment, the extracellular matrix offers several benefits in treating different chronic injuries caused due to surgery, accidents, chronic diseases, and other incidents. Moreover, heart failure and myocardial infarction incidences are increasing among the aging population. The minimally invasive treatment for these cardiovascular treatments procedures requires an extracellular matrix. A patient suffering from heart disease fails to restore the functional properties of cardiac tissue. The extracellular matrix's ability to regrow and promote adaptive repair and regeneration enables patients to recover their normal functions. Also, it has shown promising clinical outcomes for tissue engineering in the treatment of cardiovascular diseases and other health conditions.

Furthermore, the rising incidences of cardiovascular diseases are expected to drive the growth of the extracellular matrix. For instance, according to WHO data published in 2019, an estimated 17.9 million people died from CVDs 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. According to the European Cardiovascular Disease Statistics report of 2017, in Europe, each year cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in the European Union (EU).

Raw Material-based Insights

Based on the raw material, the extracellular matrix market is segmented into bovine, porcine, and other raw materials. The porcine segment is expected to hold the largest share in the market, whereas, the bovine segment is expected to register the highest CAGR during the forecast period.

Based on the application, the extracellular matrix market has been segmented into soft tissue repair, dural repair , wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. The soft tissue repair segment is likely to account for a larger market share in 2021. However, the vascular repair and reconstruction segment is expected to register a higher CAGR in the market during the forecast period.

Various companies operating in the extracellular matrix market are adopting marketing strategies, such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the increasing demand from end users.

Extracellular Matrix Market Regional Insights

The regional trends and factors influencing the Extracellular Matrix Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Extracellular Matrix Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Extracellular Matrix Market Report Scope

Extracellular Matrix Market Players Density: Understanding Its Impact on Business Dynamics

The Extracellular Matrix Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Extracellular Matrix Market are:

1. Anteris
2. Aziyo Biologics, Inc
3. Coloplast Group
4. Cook Biotech, Inc
5. DSM Biomedical

Disclaimer: The companies listed above are not ranked in any particular order.

Company Profiles

•  Anteris
• Aziyo Biologics, Inc
• Coloplast Group
• Cook Biotech, Inc
• DSM Biomedical
• Baxter
• Medtronic
• Merck KGaA
• MTF Biologics
• Smith & Nephew